Form D · Biotechnology
Opus Medical Therapies, LLC
Smyrna, GA · CIK 0001785788
Offering snapshot reported Sep 22, 2026 · SEC filing
- Reported sold
- $485K Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Sep 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2026 | Initial | $485,089 | No comparison | 4 | SEC filing |
| Sep 4, 2020 | Initial | $1,748,141 | No comparison | 12 | SEC filing |
| Aug 19, 2019 | Initial | $3,000,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598364
Source: Form D, filed Sep 22, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yen Liao | Director |
| Vivek Rajagopal | Executive |
| Jaime Sarabia | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5700 Highland Parkway Suite 200
Smyrna, GA, 30082
Phone: 404-217-1855
Smyrna, GA, 30082
Phone: 404-217-1855